INKTNasdaq

MiNK Therapeutics, Inc.

Alert me on INKT

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Oct 14 Sale Buell Jennifer Insider

1 week

+2.6%S&P +0.5%

1 month

Result in14 trading days

3 months

Result in56 trading days

6 months

Result in119 trading days

Jun 6 Sale Ryan Barbara Insider

1 week

+10.5%S&P +2.1%

1 month

+1.1%S&P +1.9%

3 months

+1.0%S&P +3.9%

6 months

Result in30 trading days

Mar 12 Sale Ryan Barbara Insider

1 week

−5.3%S&P −0.9%

1 month

+12.5%S&P +3.3%

3 months

+20.0%S&P +11.1%

6 months

+16.7%S&P +15.4%

Mar 5 Sale Ryan Barbara Insider

1 week

−6.1%S&P −2.2%

1 month

+4.5%S&P −3.0%

3 months

+16.4%S&P +11.4%

6 months

+2.6%S&P +14.1%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for INKT

40 held · newest 540 held · newest 2

Loading the filings.

See all 40 filings for INKT

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.